Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.

Mutagenesis - 1 May 2012

Wang Jing, Ding Qi, Shi Ying, Cao Qiang, Qin Chao, Zhu Jian, Chen Jiawei, Yin Changjun

Abstract excerpt

Interleukin-10 (IL-10) is a multifunctional cytokine with both immunosuppressive and anti-angiogenic properties and play an important role in the pathogenesis of cancer. IL-10-1082A>G polymorphism is the most extensively studied polymorphism in the IL-10 gene in cancer susceptibility. To date, a number of case-control studies were conducted to investigate the association between IL-10-1082A>G polymorphism and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Genetic Association Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interleukin-10

Share to Linear Models

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Share to Publication Bias

Source

Identifiers

PMID: 22058059
DOI: 10.1093/mutage/ger078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.PMID 22058059Read ↗

The -1082A>G polymorphism in promoter region of interleukin-10 and risk of digestive cancer: a meta-analysis.Semantic proximity Read ↗

The interleukin-10-1082A>G polymorphism and lymphoma risk: a meta-analysis.Semantic proximity Read ↗

Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies.Semantic proximity Read ↗

Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis.Semantic proximity Read ↗

The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.Semantic proximity Read ↗

The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

The interleukin-10 promoter polymorphism rs1800872 (-592C>A), contributes to cancer susceptibility: meta-analysis of 16,785 cases and 19,713 controls.Semantic proximity Read ↗

A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk.Semantic proximity Read ↗

ASSOCIATION OF INTERLEUKIN-10 -1082 A/G (RS1800896) POLYMORPHISM WITH SUSCEPTIBILITY TO GASTRIC CANCER: META-ANALYSIS OF 6,101 CASES AND 8,557 CONTROLS.Semantic proximity Read ↗

Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.Semantic proximity Read ↗

Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis.Semantic proximity Read ↗

Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.